ASPHALION
Laura Eder Azanza, PhD, is a highly experienced professional in pharmacovigilance and drug safety, currently serving as Drug Safety Associate Director and Deputy EU QPPV at Asphalion since June 2021. Previous roles include Senior Pharmacovigilance Specialist at OC Vigilance SL and Drug Safety Associate at ALK, where responsibilities encompassed the management of PV activities, regulatory compliance, and quality management systems. Academically, Laura holds a PhD in Biomedical Research from the University of Navarra, complemented by several master's degrees in health administration and biomedical fields. Additionally, Laura has a background in classical dance, having pursued training through the Royal Academy of Dance in London.
This person is not in any teams
ASPHALION
ASPHALION is an International Scientific and Regulatory Affairs consultancy firm based in Barcelona and Munich.They offer comprehensive services for Drug Development and Regulatory Affairs to Pharma, Biotech and Medical Devices companies.Since 2000, we have consistently grown and now have over 70 professional consultants with backgrounds inLife sciences (Pharmacy, Chemistry, Biology, Biochemistry, Biotechnology, Medicine and Veterinary Medicine). Their consultants are experts in their field and are in direct contact with EU agencies (EMA and NCAs) for the development and implementation of new regulatory standards.Asphalion provides a global range of services, for global clients. Their services range from early development, throughout the registration, until marketing and post-commercialization phases of your product.